Use of Arotinolol Pharmacotherapy to Treat Drug-induced Tremor: A Report of Three Cases

Abstract

Objective: The aim of the present study is to demonstrate the effect of arotinolol on drug-induced tremor in psychiatric patients.

Methods: This is a case study of three psychiatric patients with the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) diagnosis of major depressive disorder who were treated in inpatient or outpatient psychiatric settings with antidepressant or antipsychotics. Patients developed tremor. Arotinolol was started to treat the tremor.

Results: Drug-induced tremor almost resolved completely. No adverse effects were observed.

Conclusion: We have presented a case series of drug-induced tremors that responded well to treatment with arotinolol, which appears to be a safe and well-tolerated drug in the dose ranges used. The possible utility of arotinolol to treat drug-induced tremor deserves attention and further investigation.

Key words

arotinolol - tremor - treatment

• References

• 1 Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J 1990; 83: 525-532
• 2 Lejoyeux M, Rouillon F, Adès J et al. Neural symptoms induced by tricyclic antidepressants: phenomenology and pathophysiology. Acta Psychiatr Scand 1992; 85: 249-256
• 3 Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol 2005; 4: 866-876
• 4 Karas BJ, Wilder BJ, Hammond EJ et al. Valproate tremors. Neurology 1982; 32: 428-432
• 5 Gelenberg AJ, Jefferson JW. Lithium tremor. J Clin Psychiatry 1995; 56: 283-287
• 6 Reutens DC, Duncan JS, Patsalos PN. Disabling tremor after lamotrigine with sodium valproate. Lancet 1993; 342: 185-186
• 7 Arbaizar B, Gómez-Acebo I, Llorca J. Postural induced-tremor in psychiatry. Psychiatry Clin Neurosci 2008; 62: 638-645
• 8 Larsen TA, Calne DB. Essential tremor. Clin Neuropharmacol 1983; 6: 185-206
• 9 Wu H, Zhang Y, Huang J et al. Clinical trial of arotinolol in the treatment of hypertension: dippers vs. non-dippers. Hypertens Res 2001; 24: 605-610
• 10 Zappia M, Albanese A, Bruno E et al. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol 2013; 260: 714-740
• 11 Deuschl G, Bain P, Brin M. Consensus Statement of the Movement Disorder Society on Tremor. Mov Disord 1998; 13: 2-23
• 12 Zesiewicz TA, Elble R, Louis ED et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005; 64: 2008-2020
• 13 Lee KS, Kim JS, Kim JW et al. A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor. Parkinsonism Relat Disord 2003; 9: 341-347
• 14 Hara Y, Sugimoto S, Ono H. Effect of arotinolol on the incomplete tetanic contractions of the cat soleus muscle. – Relation to its anti-tremorgenic action. Nihon Yakurigaku Zasshi 1993; 102: 141-151
• 15 Mitsuda M, Nomoto M, Iwata S. Effects of beta-blockers and nicardipine on oxotremorine-induced tremor in common marmosets. Jpn J Pharmacol 1999; 81: 244-246
• 16 Lakie MD, Hayes NR, Combes N et al. Is postural tremor size controlled by interstitial potassium concentration in muscle?. J Neurol Neurosurg Psychiatry 2004; 75: 1013-1018
• 17 Mai J, Olsen RB. Depression of essential tremor by alpha-adrenergic blockade. J Neurol Neurosurg Psychiatry 1981; 44: 1171
• 18 Morita S, Miwa H, Kondo T. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord 2005; 11: 101-103
• 19 Kuroda Y, Kakigi R, Shibasaki H. Treatment of essential tremor with arotinolol. Neurology 1988; 38: 650-652
• 20 Lapierre YD. Control of lithium tremor with propranolol. Can Med Assoc J 1976; 114: 619-620 624